Welcome to our dedicated page for Genpact SEC filings (Ticker: G), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Genpact's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Genpact's regulatory disclosures and financial reporting.
Genpact Limited (G) appointed Sumita Pandit as Senior Vice President and Chief Financial Officer effective September 9, 2026, replacing Michael Weiner, who will stay in a transitional role through March 31, 2027 and whose departure is stated as not related to accounting or internal control disagreements.
Pandit’s employment agreement provides a $750,000 annual base salary, an annual target bonus equal to 120% of base salary, and a one-time bonus totaling $3,000,000 payable in December 2026 and December 2027, subject to performance. She will receive initial equity awards of PSUs and RSUs each valued at $2,675,000, with vesting based on performance and service. The agreement also outlines severance, accelerated vesting and health benefit payments upon certain terminations, including enhanced treatment following a change of control, subject to a release of claims and restrictive covenants.
Genpact LTD (G) reported that Senior Vice President Anil Nanduru sold 6,191 Common Shares of Genpact on 2026-08-19 in an open market or private transaction at $37.03 per share. Following this sale, Nanduru directly holds 70,253 Common Shares of Genpact.
Genpact LTD (symbol: G) is the issuer of record for a Form S-4 filing submitted to the SEC.
Genpact Limited (G) received a notice under Rule 144 that officer Anil Nanduru plans to sell 6,191 shares of common stock through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $229,221.78. The shares relate to performance shares and are listed on the NYSE under CUSIP 168034407. In the prior three months, Nanduru reported additional sales of 11,852 shares for $401,972.43 on August 12, 2026 and 17,243 shares for $585,568.83 on August 11, 2026.
Genpact LTD (G) reported that Senior Vice President Sameer Dewan sold a total of 14,972 Common Shares on 2026-08-14 in open market or private transactions. One block of 1,654 shares was sold at $34.10 per share, and another block of 13,318 shares was sold at a weighted average price of $34.10, with sales prices ranging from $34.10 to $34.11. Post-transaction share holdings were not reported in this filing.
Issuer G filed to permit the resale of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The notice covers up to 14,972 shares of common stock, with an approximate aggregate market value of $510,558.52 as of the planned sale date of August 14, 2026.
The shares derive from prior awards and purchases, including Employee Stock Purchase Plan acquisitions between 2021 and 2023 and grants of performance shares and restricted stock that became or are scheduled to become issuable in 2024 and 2026.
Genpact LTD Chief Financial Officer Michael Hal Weiner reported a sale of 5,900 Common Shares on August 13, 2026 in an open-market or private transaction at $34.04 per share. Following this sale, he directly holds 176,027 Common Shares, including 1,591 shares under the Genpact Employee Stock Purchase Plan, of which 53 ESPP shares were acquired since his March 12, 2026 ownership report.
An affiliate of the issuer with ticker G filed a notice of proposed sale of restricted securities. The filing covers up to 5,900 shares of common stock, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE, with an indicated aggregate value of $200,836.00 as of a planned sale date of August 13, 2026. The shares relate to restricted stock originally issued by the company on January 10, 2025 in two blocks of 2,492 and 3,408 shares.
Genpact LTD Senior Vice President Nanduru Anil reported two open-market sales of common shares. On August 11, 2026, he sold 17,243 shares at a weighted average price of $33.96 per share, with actual prices ranging from $33.95–$33.99. On August 12, 2026, he sold 11,852 shares at a weighted average price of $33.92, with actual prices from $33.90–$33.94. The transactions were reported as direct ownership sales and are not indicated as being under a Rule 10b5-1 trading plan.
AQR Capital Management, LLC and its parent AQR Capital Management Holdings, LLC report beneficial ownership of Genpact LTD common shares. As of June 30, 2026, they jointly report 8,601,538 common shares of Genpact LTD, representing 5.07% of the outstanding class.
Both entities report shared voting power over 8,394,453 shares and shared dispositive power over 8,601,538 shares, with no sole voting or dispositive power. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC, and the Schedule is filed on behalf of both entities.